Is EINECS 244-759-8 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EINECS 244-759-8? Is EINECS 244-759-8 safe for nursing mother and child? Does EINECS 244-759-8 extracts into breast milk? Does EINECS 244-759-8 has any long term or short term side effects on infants? Can EINECS 244-759-8 influence milk supply or can EINECS 244-759-8 decrease milk supply in lactating mothers?
EINECS 244-759-8 lactation summary
- DrLact safety Score for EINECS 244-759-8 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of EINECS 244-759-8 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that EINECS 244-759-8 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of EINECS 244-759-8 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About EINECS 244-759-8 usage in lactation
EINECS 244-759-8 is excreted into breast milk in non-significant amount. Hence, reportedly gastrointestinal side effects on breastfed infants are hardly believable. When apply on skin systemic absorption is very low.
Answer by DrLact: About EINECS 244-759-8 usage in lactation
Although EINECS 244-759-8 has low levels in breastmilk, one center reported that they had received reports of adverse renal and gastrointestinal side effects in breastfed infants whose mothers were taking EINECS 244-759-8. Other agents are preferred, especially while nursing a newborn or preterm infant.
EINECS 244-759-8 Side Effects in Breastfeeding
All adverse reactions in breastfed infants reported in France between January 1985 and June 2011 were compiled by a French pharmacovigilance center. Of 174 reports, EINECS 244-759-8 was reported to cause adverse reactions in 8 infants and to be one of the drugs most often suspected in serious adverse reactions, such as esophageal ulceration, erosive gastritis, meningeal hemorrhage, and renal insufficiency.[2]
Alternate Drugs
Nabumetone(Low Risk)
Ketoprofen(Safe)
Fenoprofen(Safe)
Aspirin(Low Risk)
Etodolac(Low Risk)
Meloxicam(Low Risk)
Oxaprozin(Low Risk)
Diflunisal(Low Risk)
Mefenamic Acid(Safe)
Diclofenac(Safe)
Meclofenamate(Low Risk)
Tolmetin(Safe)
Celecoxib(Safe)
Ketorolac(Safe)
Sulindac(Low Risk)
Indomethacin(Safe)
Piroxicam(Safe)
Ibuprofen(Safe)
Naproxen(Low Risk)
Dipyrone(Low Risk)
Flurbiprofen(Safe)
Nabumetone(Low Risk)
Ketoprofen(Safe)
Fenoprofen(Safe)
Aspirin(Low Risk)
Etodolac(Low Risk)
Meloxicam(Low Risk)
Oxaprozin(Low Risk)
Diflunisal(Low Risk)
Mefenamic Acid(Safe)
Diclofenac(Safe)
Meclofenamate(Low Risk)
Tolmetin(Safe)
Celecoxib(Safe)
Ketorolac(Safe)
Sulindac(Low Risk)
Indomethacin(Safe)
Piroxicam(Safe)
Ibuprofen(Safe)
Naproxen(Low Risk)
Dipyrone(Low Risk)
Flurbiprofen(Safe)